Thrombolytic Therapy in the Current ERA: Myocardial Infarction and Beyond
Related Experiment Video
Updated: Feb 16, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Patrick Proctor1, Massoud A Leesar1, Arka Chatterjee1
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, United States.
Insights
Thrombolytic therapy, crucial in cardiology, remains vital for acute myocardial infarction and ischemic stroke patients lacking percutaneous coronary intervention (PCI) access. Its evolving applications are explored.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Thrombolytic therapy initiated modern cardiology.
- Primary percutaneous coronary intervention (PCI) now dominates acute myocardial infarction treatment.
- Thrombolytics remain essential for patients without PCI access and for acute ischemic stroke.
Purpose of the Study:
- To review the history and evidence base of thrombolytic agents.
- To summarize current applications of thrombolytics in cardiovascular disease.
- To highlight innovative uses of thrombolytic therapy.
Main Methods:
- Literature review of thrombolytic therapy in cardiovascular disease.
- Analysis of historical evidence and current clinical practice.
- Exploration of emerging therapeutic uses.
Main Results:
- Thrombolytic therapy has a significant historical impact on cardiology.
- Despite PCI advancements, thrombolytics retain importance for specific patient groups.
- Novel applications for thrombolytics are emerging.
Conclusions:
- Thrombolytic agents continue to play a critical role in cardiovascular medicine.
- Understanding the evidence base and evolving uses of thrombolytics is crucial.
- Thrombolytics offer therapeutic options for underserved populations and new conditions.
Abstract:
Thrombolytic therapy kick-started the era of modern cardiology but in the last few decades it has been largely supplanted by primary percutaneous coronary intervention (PCI) as the go-to treatment for acute myocardial infarction. However, these agents remain important for vast populations without access to primary PCI and acute ischemic stroke. More innovative uses have recently come up for the treatment of a variety of conditions. This article summarizes the history, evidence base and current use of thrombolytics in cardiovascular disease.
Related Concept Videos
Gene Therapy
Electrical Current
Group Therapy
Current Density
Eddy Currents
Other major applications of eddy currents appear in metal detectors and the braking systems of trains and roller...
Displacement Current

